Physician profile
Jeffrey Gilsdorf
NPI 1477524486
$540.16
in general payments reported to CMS, 2019-2025
16 companies · $73.29 in 2025
The $73.29 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $65.51 · 2022: $61.82 · 2023: $120 · 2024: $90.14 · 2025: $73.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $96.38 | 2019-2022 | |
| Depuy Synthes Sales INC. | $90.02 | 2019-2025 | Monovisc, Orthovisc, Peak |
| Amgen INC. | $38.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $37.58 | 2023 | Iovera, Zilretta |
| Zimmer Biomet Holdings, INC. | $37.21 | 2020 | |
| Smith+Nephew, INC. | $27.54 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Pacira Therapeutics, INC. | $27.27 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $26.16 | 2025 | Euflexxa |
| Bioventus LLC | $25.20 | 2024 | Exogen Ultrasound Bone Healing System |
| Radius Health, INC. | $24.03 | 2023 | Tymlos |
| Electronic Waveform Lab, INC. | $23.96 | 2023-2024 | |
| Pfizer INC. | $18.20 | 2024 | |
| Almatica Pharma LLC | $17.65 | 2025 | Teriparatide |
| Fresenius Kabi USA, LLC | $17.64 | 2023 | Idacio |
| Omeros Corporation | $16.45 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $16.06 | 2024 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gilsdorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.